Early Antiviral Therapy in Pediatric Outpatients and Risk of Influenza-Related Hospitalization

Ya-Ning Huang1,2,3, Chia-Jung Chang4, Yu-Ling Dai1,2

  • 1Department of Pediatrics, Hsinchu Municipal MacKay Children's Hospital, Hsinchu, Taiwan.

Pediatrics
|August 16, 2026
PubMed

Insights

Early antiviral therapy significantly lowers hospitalization risk for children with influenza. Prompt treatment within 48 hours of symptom onset is crucial for preventing severe illness in pediatric patients.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Pharmacotherapy

Background:

  • Limited evidence exists on antiviral therapy's effectiveness in preventing severe influenza illness and hospitalization in children.
  • Influenza poses a significant risk for severe outcomes in pediatric populations.

Purpose of the Study:

  • To evaluate the effectiveness of early antiviral therapy in reducing severe illness and hospitalization in pediatric influenza patients.
  • To test the hypothesis that antiviral treatment initiated within 48 hours of symptom onset improves outcomes.

Main Methods:

  • A multicenter, retrospective case-control study involving pediatric outpatients with confirmed influenza (2020-2023).
  • Cases were hospitalized or deceased children; controls were non-hospitalized children, matched by age and visit date.
  • Conditional logistic regression analyzed early (within 48 hours) vs. delayed/no antiviral therapy.

Main Results:

  • Early antiviral therapy was associated with an 81% reduced risk of hospitalization (aOR, 0.19).
  • This protective effect was consistent across age groups: 5 years or younger (aOR, 0.19) and older than 5 years (aOR, 0.15).
  • Sensitivity analyses confirmed the robustness of these findings across different antiviral agents.

Conclusions:

  • Early antiviral therapy substantially decreases the risk of severe illness and hospitalization in pediatric influenza patients.
  • The findings support the prompt initiation of antiviral treatment for children diagnosed with influenza.
Abstract

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.